Trade Summary

3 days ago, Waddill William D., serving as Dir at Protagonist Therapeutics, Inc (PTGX), sold 9,000 shares at $117.94 per share, for a total transaction value of $1,061,460.00. Following this transaction, Waddill William D. now holds 7,825 shares of PTGX.

This sale represents a 53.49% decrease in Waddill William D.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 at 4:10 PM ET, 2 days after the trade was made.

Protagonist Therapeutics, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.